Moderna
MRNA
#1611
Rank
S$13.71 B
Marketcap
$35.48
Share price
-1.50%
Change (1 day)
-76.05%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -S$4.86 Billion

According to Moderna 's latest financial reports the company's current earnings are S$3.19 Billion. , an increase over its 2023 earnings that were of -S$5.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -S$4.72 Billion-8.22%
2023 -S$5.14 Billion-140.65%
2022 S$12.63 B-27.81%
2021 S$17.49 B-1911.15%
2020 -S$0.97 Billion44.7%
2019 -S$0.67 Billion28.63%
2018 -S$0.52 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$60.76 Million-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.89 B-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$54.93 Million-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.31 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.93 B-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.79 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.93 B-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA